The Coronavirus pandemic and thus the following lockdown has forced schools and colleges across India to temporarily shut and this unprecedented move had created a huge gap within the education bodies despite the central and the government doing their best to support e-learning and online education. Globally, the Indian Education sector is amongst the most important, with an in-depth network of quite 1.4 million schools and 993 Universities, 39931 Colleges, and 10725 Stand-Alone Institutions listed on the AISHE web portal. Because the Indian education system was mostly supported by the offline system and classes. Most of the first, and secondary schooling sectors were all supported offline education system has got to opt the web classes for empowering the education, and for the advantages of the scholars. Many faculties within the country have switched to online classes thanks to the lockdown, but one in four students is unable to connect because they don’t have a laptop, desktop, or tablet, according to a survey by economic times.

No abstract

No abstract

The overarching aim of pharmacovigilance is to ensure the safe and effective usage of medication across the population and optimise medicines through holistic considerations. However, within the heterogeneous elderly population, several unique factors are at play, limiting the ability of clinicians to fulfil this aim. A matured physiology influencing the response and effects of drugs, increased polypharmacy enabling drugdrug interactions, and greater consumption of concurrent herbal medicines predispose patients to harmful drug events. This increasingly multimorbid subpopulation requires complex pharmaceutical regimens encouraging inappropriate prescribing and medicine non-adherence leading to suboptimal therapy. Furthermore, restrictive practices in clinical trials commonly exclude elderly patients creating disparities from expected findings within a real-world setting. These issues create an environment where elderly patients are at a heightened risk of adverse drug events and clinicians are forced to make significant decisions from limited information. With projections showing that this demographic will continue growing in size, the true burden of these limiting factors is yet to be realised.

Cancer is emerging as a major public health concern for the entire globe. According to the World Cancer Report, cancer is the world's second most common cause of death. This poses a rapidly increasing threat worldwide to individuals, health systems and economies.Cancer patients are more susceptible to critical illness and death as compared to the general infected population. Various cohort studies were conducted in China between December 2019 to June 2020;it was inspected that among overall cancer patients admitted in hospital during the pandemic, 79% were Covid-19 Positive among which 39% died in ICU; whereas among all general population admitted to the same hospital 37% were Covid positive out of which 8% died. It suggests that the cancer patients are at more risk due to Covid-19 pandemic outbreak. In order to prevent 7 million cancer deaths over the next decade, countries must expedite their health care system. In low-income and middle-income countries,during the next decade, the incidence of cancer is expected to almost double.In 2018 India had about 1.16 million cancer cases, 784800 cancer deaths amongits population of 1.35 billion people. Furthermore, the treatment cost for more than 40% of cancer hospitalization is made by selling the assets and borrowing from relatives; they incur out-of-pocket (OOPE) expenditure in the private sector and can cost more than 20 percent of their annual per capita household spending.And over 76% of cancer patient families faced financial problems during treatment. The main aim objective of the study was to understand the cancer scenario in India, its treatment cost implications and various treatment facilities and different funding assistance cum Health schemes implemented by central and state governments in India.The data is collected from secondary sources and descriptive study was performed. Therefore in conclusion we find that, we require effective prevention for surviving against cancer along with the proper awareness of the funding schemes by the government for the cancer patients and greater investment in the healthcare infrastructure needs proper attention.